Curcumin Attenuates Acrolein-induced COX-2 Expression and Prostaglandin Production in Human Umbilical Vein Endothelial Cells

키워드

참고문헌 (34)

1. Geovanini GR, "Atherosclerosis and inflammation: overview and updates", Clin Sci(Lond), 132, pp.1243~1252 (2018)
2. Libby P, "Inflammation in atherosclerosis", Arterioscler Thromb Vasc Biol, 32, pp.2045~2051 (2012)
3. Ambrose JA, "The pathophysiology of cigarette smoking and cardiovascular disease : an update", J Am Coll Cardiol, 43, pp.1731~1737 (2004)
4. Stevens JF, "Acrolein : sources, metabolism, and biomolecular interactions relevant to human health and disease", Mol Nutr Food Res, 52, pp.7~25 (2008)
5. Thweatt WD, "Measurement of acrolein and 1, 3-butadiene in a single puff of cigarette smoke using lead-salt tunable diode laser infrared spectroscopy", Spectrochim Acta A Mol Biomol Spectrosc, 67, pp.16~24 (2007)
6. Zirak MR, "Mechanisms behind the atherothrombotic effects of acrolein, a review", Food Chem Toxicol, 129, pp.38~53 (2019)
7. Park YS, "Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells : roles of p38 MAP kinase", Arterioscler Thromb Vasc Biol, 27, pp.1319~1325 (2007)
8. Park YS, "Acrolein induces inflammatory response underlying endothelial dysfunction : a risk factor for atherosclerosis", Ann N Y Acad Sci, 1126, pp.185~189 (2008)
9. Rumzhum NN, "Cyclooxygenase 2 : its regulation, role and impact in airway inflammation", Clin Exp Allergy, 46, pp.397~410 (2016)
10. Gupta SC, "Therapeutic roles of curcumin : lessons learned from clinical trials", AAPS J, 15, pp.195~218 (2013)
11. Kunnumakkara AB, "Curcumin, the golden nutraceutical : multitargeting for multiple chronic diseases", Br J Pharmacol, 174, pp.1325~1348 (2017)
12. Binion DG, "Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition", Gut, 57, pp.1509~1517 (2008)
13. Devassy JG, "Curcumin and cancer : barriers to obtaining a health claim", Nutr Rev, 73, pp.155~165 (2015)
14. Gardener SL, "Diet and inflammation in Alzheimer's disease and related chronic diseases : a review", J Alzheimers Dis, 50, pp.301~334 (2016)
15. Karimian MS, "Curcumin and endothelial function : evidence and mechanisms of protective effects", Curr Pharm Des, 23, pp.2462~2473 (2017)
16. Midura-Kiela MT, "Curcumin inhibits interferon-γ signaling in colonic epithelial cells", Am J Physiol Gastrointest Liver Physiol, 302, pp.G85~G96 (2012)
17. 조재위, "Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets", Experimental and Molecular Medicine, 37(3), pp.186~192 (2005), 생화학분자생물학회
18. He Y, "Curcumin, inflammation, and chronic diseases : how are they linked?", Molecules, 20, pp.9183~9213 (2015)
19. Lee SE, "Autophagy in crotonaldehyde-induced endothelial toxicity", Molecules, 24, pp.E1137~ (2019)
20. Seung Eun Lee, "Effect of crotonaldehyde on the induction of COX-2 expression in human endothelial cells", Molecular & Cellular Toxicology, 13(3), pp.345~350 (2017), 대한독성 유전단백체 학회
21. 이승은, "Korean Red Ginseng water extract inhibits COX-2 expression by suppressing p38 in acrolein-treated human endothelial cells", Journal of Ginseng Research, 38(1), pp.34~39 (2014), 고려인삼학회[DOI]
22. Haberzettl P, "Role of endoplasmic reticulum stress in acrolein-induced endothelial activation", Toxicol Appl Pharmacol, 234, pp.14~24 (2009)
23. Gómez-Hernández A, "Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis : regulation by nuclear factor-κB", Atherosclerosis, 187, pp.139~149 (2006)
24. Hatcher H, "Curcumin : from ancient medicine to current clinical trials", Cell Mol Life Sci, 65, pp.1631~1652 (2008)
25. Burge K, "Curcumin and intestinal inflammatory diseases : molecular mechanisms of protection", Int J Mol Sci, 20, pp.E1912~ (2019)
26. Sharma C, "Curcumin down regulates smokeless tobacco-induced NF-κB activation and COX-2 expression in human oral premalignant and cancer cells", Toxicology, 228, pp.1~15 (2006)
27. Lelli D, "Curcumin use in pulmonary diseases : state of the art and future perspectives", Pharmacol Res, 115, pp.133~148 (2017)
28. Ghosh S, "The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease : a recent update", Food Chem Toxicol, 83, pp.111~124 (2015)
29. Shehzad A, "New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases", Eur J Nutr, 50, pp.151~161 (2011)
30. Sikora E, "Curcumin, inflammation, ageing and age-related diseases", Immun Ageing, 7, pp.1~ (2010)
31. Camacho-Barquero L, "Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis", Int Immunopharmacol, 7, pp.333~342 (2007)
32. Ramírez-Tortosa MC, "Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis", Atherosclerosis, 147, pp.371~378 (1999)
33. Haybar H, "Endothelial cells : from dysfunction mechanism to pharmacological effect in cardiovascular disease", Cardiovasc Toxicol, 19, pp.13~22 (2019)
34. Incalza MA, "Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases", Vascul Pharmacol, 100, pp.1~19 (2018)

관련 논문AI추천